Status:
COMPLETED
Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Hammersmith Hospitals NHS Trust
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
We will address coagulation parameters in hereditary haemorrhagic telangiectasia (HHT) compared to controls.
Detailed Description
The inherited disease hereditary haemorrhagic telangiectasia (HHT) causes bleeding from dilated fragile vessels, particularly in the nose and gut. However, many HHT patients develop deep venous thromb...
Eligibility Criteria
Inclusion
- Patients with HHT and normal controls
Exclusion
- Previous thrombosis, recent ill health
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00230659
Start Date
August 1 2004
End Date
July 1 2008
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN